Activation of hepatic stellate cells--a key issue in liver fibrosis.

Hepatic fibrosis describes the presence of excess collagen due to new fiber formation, laid down as part of the tissue repair response to chronic liver injury. The causes of injury include toxins, disorders of the immune system, viral and parasitic infections, as well as rarer liver diseases such as haemochromatosis, Wilson's disease and galactosaemia. Whatever the cause of injury, the cells and soluble factors contributing to this wound healing response are similar. The principal effector of hepatic fibrogenesis is now widely recognized as the hepatic stellate cell. Stellate cells are usually quiescent cells, but in response to liver injury they undergo an activation process in which they become highly proliferative and synthesize a fibrotic matrix rich in type I collagen. Initiation of stellate cell activation is largely due to paracrine stimulation, whereas perpetuation of activation involves autocrine as well as paracrine loops, and is dependent on a number of functional changes. The principal paracrine and autocrine factors currently thought to be involved in these processes are discussed in this review, as are the roles of the extracellular matrix, the nuclear receptor superfamily, non-peptide ligands, and oxidative stress.

[1]  K. S. Lee,et al.  Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. , 1995, The Journal of clinical investigation.

[2]  A. Gressner,et al.  Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells. , 1997, Gastroenterology.

[3]  G. Brittenham,et al.  Experimental liver cirrhosis induced by alcohol and iron. , 1995, The Journal of clinical investigation.

[4]  E. Tekle,et al.  Epidermal Growth Factor (EGF)-induced Generation of Hydrogen Peroxide , 1997, The Journal of Biological Chemistry.

[5]  J. Massagué,et al.  Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[6]  L. Gesualdo,et al.  Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors. , 1992, The American journal of physiology.

[7]  G. Davis,et al.  Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. , 2000, Gastroenterology.

[8]  S. Nakanishi,et al.  Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.

[9]  S. Friedman,et al.  CYP2E1‐mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells , 1999, Hepatology.

[10]  M. Yanagisawa,et al.  The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Peter Schirmacher,et al.  Hepatocyte growth factor/hepatopoietin A is expressed in fat‐storing cells from rat liver but not myofibroblast‐like cells derived from fat‐storing cells , 1992, Hepatology.

[12]  L. Gesualdo,et al.  Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. , 1989, The Journal of clinical investigation.

[13]  H. Popper,et al.  Capillarization of hepatic sinusoids in man. , 1963, Gastroenterology.

[14]  D. Aron,et al.  Secretion of insulin-like growth factor-I and binding proteins by rat liver fat-storing cells: regulatory role of platelet-derived growth factor. , 1990, Endocrinology.

[15]  S. Friedman,et al.  Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. , 1989, The Journal of biological chemistry.

[16]  M. Arthur,et al.  The plasminogen‐activating system in hepatic stellate cells , 1996, Hepatology.

[17]  J. Egido,et al.  Overexpression of extracellular matrix proteins in renal tubulointerstitial cells by platelet-activating-factor stimulation. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  G. Poli Pathogenesis of liver fibrosis: role of oxidative stress. , 2000, Molecular aspects of medicine.

[19]  N. Hayashi,et al.  Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha. , 1995, Journal of hepatology.

[20]  H. Tsukamoto,et al.  Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease , 1995, Hepatology.

[21]  P. Desmond,et al.  Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor β in a bile duct ligated rat model of cirrhosis , 1997, Hepatology.

[22]  G. Zimmerman,et al.  Platelet-activating factor and related lipid mediators. , 2000, Annual review of biochemistry.

[23]  C. Lieber,et al.  Acetaldehyde selectively stimulates collagen production in cultured rat liver fat‐storing cells but not in hepatocytes , 1990, Hepatology.

[24]  D. Rockey The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide , 1997, Hepatology.

[25]  S. Wahl,et al.  In situ expression of transforming growth factor beta in streptococcal cell wall-induced granulomatous inflammation and hepatic fibrosis. , 1990, Growth factors.

[26]  M. Czaja,et al.  Ito cell expression of a nuclear retinoic acid receptor , 1992, Hepatology.

[27]  J. Wrana,et al.  Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. , 1989, The Journal of biological chemistry.

[28]  V. Paradis,et al.  In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. , 1997, Journal of clinical pathology.

[29]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[30]  A. J. Valente,et al.  Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. , 1993, The Journal of clinical investigation.

[31]  P. Heinrich,et al.  Induction of rat α2‐macroglobulin in vivo and in hepatocyte primary cultures: synergistic action of glucocorticoids and a Kupffer cell‐derived factor , 1984, FEBS letters.

[32]  A. Cederbaum Introduction: role of lipid peroxidation and oxidative stress in alcohol toxicity , 1989 .

[33]  J. Witztum,et al.  Excess iron induces hepatic oxidative stress and transforming growth factor β1 in genetic hemochromatosis , 1997, Hepatology.

[34]  M. Arthur,et al.  Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. , 2000, Journal of hepatology.

[35]  Cho-il Kim,et al.  S‐Adenosyl‐L‐methionine attenuates alcohol‐induced liver injury in the baboon , 1990, Hepatology.

[36]  A Geerts,et al.  History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells , 2001, Seminars in liver disease.

[37]  G. Dubyak,et al.  Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells. , 1991, The American journal of physiology.

[38]  P. Muriel,et al.  Dose-response studies of interferon-alpha 2b on liver fibrosis and cholestasis induced by biliary obstruction in rats. , 1997, Pharmacology.

[39]  J. Prieto,et al.  Randomised trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia. , 1993, Journal of hepatology.

[40]  R. Hammer,et al.  Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. , 1997, The Journal of clinical investigation.

[41]  S. Milani,et al.  Expression of platelet‐derived growth factor in a model of acute liver injury , 1994, Hepatology.

[42]  T. Kitamoto,et al.  Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo. , 1999, Journal of hepatology.

[43]  Pieter,et al.  Insulin‐like growth factor II/mannose 6‐phosphate‐receptor expression in liver and serum during acute CCl4 intoxication in the rat , 1996, Hepatology.

[44]  H. Reeves,et al.  Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture. , 2000, Journal of hepatology.

[45]  Anping Chen,et al.  Platelet-derived growth factor is a principal inductive factormodulating mannose 6-phosphate/insulin-like growth factor-II receptorgene expression via a distal E-box in activated hepatic stellate cells. , 2000, The Biochemical journal.

[46]  K. Nose,et al.  Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells , 1994, The Journal of cell biology.

[47]  S. Friedman,et al.  Hepatic lipocytes: a major target for endothelin-1. , 1995, Journal of hepatology.

[48]  D. Leroith Insulin-like growth factor receptors and binding proteins. , 1996, Bailliere's clinical endocrinology and metabolism.

[49]  M. Rugge,et al.  Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy. , 1996, Journal of hepatology.

[50]  A. Gressner,et al.  Hepatocyte-conditioned medium potentiates insulin-like growth factor (IGF) 1 and 2 stimulated DNA synthesis of cultured fat storing cells. , 2008, Liver.

[51]  S. Strömblad,et al.  The coupling between transforming growth factor-alpha and the epidermal growth factor receptor during rat liver regeneration. , 1993, Experimental cell research.

[52]  F. Weiner,et al.  Increased transforming growth factor-β1 gene expression in human liver disease , 1992 .

[53]  R. Rippe,et al.  Expression of Interleukin-10 by in Vitro and in Vivo Activated Hepatic Stellate Cells* , 1998, The Journal of Biological Chemistry.

[54]  M. Czaja,et al.  In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis , 1989, The Journal of cell biology.

[55]  H. Herbst,et al.  Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. , 1996, The American journal of pathology.

[56]  D. Brenner,et al.  The role of Smad3 in mediating mouse hepatic stellate cell activation , 2001, Hepatology.

[57]  H. Senoo,et al.  Morphology of sites of adhesion between hepatic stellate cells (vitamin A‐storing cells) and a three‐dimensional extracellular matrix , 1998, The Anatomical record.

[58]  M. Arthur Iron overload and liver fibrosis , 1996, Journal of gastroenterology and hepatology.

[59]  S. Milani,et al.  Expression of the thrombin receptor in human liver: Up‐regulation during acute and chronic injury , 1998, Hepatology.

[60]  L. Kaplan Leptin, obesity, and liver disease. , 1998, Gastroenterology.

[61]  A. Gentilini,et al.  Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells. , 2000, Journal of hepatology.

[62]  Anping Chen,et al.  The DNA Binding Protein BTEB Mediates Acetaldehyde-Induced, Jun N-Terminal Kinase-Dependent αI(I) Collagen Gene Expression in Rat Hepatic Stellate Cells , 2000, Molecular and Cellular Biology.

[63]  H. Tsukamoto,et al.  Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. , 1997, The American journal of physiology.

[64]  M. Olive,et al.  Tumor Necrosis Factor Alpha Inhibits Type I Collagen Synthesis through Repressive CCAAT/Enhancer-Binding Proteins , 2000, Molecular and Cellular Biology.

[65]  F. Anania,et al.  Transdifferentiation of rat hepatic stellate cells results in leptin expression. , 1998, Biochemical and biophysical research communications.

[66]  S. Kojima,et al.  Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF‐β in liver stellate cells , 1997 .

[67]  K. Decker,et al.  Regulation of the mRNA expression for tumor necrosis factor-α in rat liver macrophages , 1994 .

[68]  H. Tsukamoto,et al.  Stimulation of hepatic lipocyte collagen production by Kupffer cell‐derived transforming growth factor β: Implication for a pathogenetic role in alcoholic liver fibrogenesis , 1990, Hepatology.

[69]  A. Gressner,et al.  Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta. , 1989, Biochemical and biophysical research communications.

[70]  V. Desmet,et al.  Distribution of the VLA family of integrins in normal and pathological human liver tissue. , 1991, Gastroenterology.

[71]  D. Robyr,et al.  Nuclear hormone receptor coregulators in action: diversity for shared tasks. , 2000, Molecular endocrinology.

[72]  N. Davidson,et al.  Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation. , 1991, The Biochemical journal.

[73]  S. Friedman,et al.  Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. , 1992, The Biochemical journal.

[74]  V. Paradis,et al.  In situ detection of lipid peroxidation by‐products in chronic liver diseases , 1997, Hepatology.

[75]  F. Marra,et al.  Cytokine Receptors and Signaling in Hepatic Stellate Cells , 2001, Seminars in liver disease.

[76]  A. Gentilini,et al.  Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. , 1993, Biochemical and biophysical research communications.

[77]  Y. Takei,et al.  Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals , 2001, Hepatology.

[78]  A. Gressner,et al.  Effects of murine recombinant interferon-gamma on rat liver fat storing cell proliferation, cluster formation and proteoglycan synthesis. , 1990, Biochemical pharmacology.

[79]  D M Bissell,et al.  The role of alpha1beta1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture. , 1997, The Journal of biological chemistry.

[80]  D. Crabb,et al.  The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease. , 2000, Liver.

[81]  A. Casini,et al.  Acetaldehyde-protein adducts, but not lactate and pyruvate, stimulate gene transcription of collagen and fibronectin in hepatic fat-storing cells. , 1993, Journal of hepatology.

[82]  V. Carloni,et al.  Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. , 1994, Gastroenterology.

[83]  D. Rockey,et al.  Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis. , 1994, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[84]  S. Milani,et al.  Transforming growth factor‐β1 regulates platelet‐derived growth factor receptor β subunit in human liver fat‐storing cells , 1995 .

[85]  E. Wisse,et al.  Insulinlike growth factor—ii/mannose 6‐phosphate receptor is expressed on ccl4‐exposed rat fat‐storing cells and facilitates activation of latent transforming growth factor‐β in cocultures with sinusoidal endothelial cells , 1995 .

[86]  J. Maher,et al.  Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. , 1987, The Journal of clinical investigation.

[87]  Jeffrey L. Wrana,et al.  Mechanism of activation of the TGF-β receptor , 1994, Nature.

[88]  R. Derynck The Physiology Of Transforming Growth Factor-α , 1992 .

[89]  S. Milani,et al.  Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. , 1993, Gastroenterology.

[90]  G. Ramadori,et al.  Effect of tumour necrosis factor-alpha on proliferation, activation and protein synthesis of rat hepatic stellate cells. , 1997, Journal of hepatology.

[91]  T. Finkel Oxygen radicals and signaling. , 1998, Current opinion in cell biology.

[92]  J. Iredale Hepatic Stellate Cell Behavior during Resolution of Liver Injury , 2001, Seminars in liver disease.

[93]  M. Vidaud,et al.  Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group. , 1999, Gastroenterology.

[94]  M. Buck,et al.  LAP (NF-IL6) transactivates the collagen alpha 1(I) gene from a 5' regulatory region. , 1994, The Journal of clinical investigation.

[95]  C. Lieber,et al.  Hepatic vitamin A depletion after chronic ethanol consumption in baboons and rats. , 1981, The Journal of nutrition.

[96]  M J Banda,et al.  Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. , 1988, Science.

[97]  S. Pestka The human interferon alpha species and receptors. , 2000, Biopolymers.

[98]  H. Abboud,et al.  Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells. , 1994, Gastroenterology.

[99]  C. Lieber,et al.  Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat‐storing cells through a protein synthesis–dependent mechanism , 1991, Hepatology.

[100]  D. Dhumeaux,et al.  Interferon alfa and gamma inhibit proliferation and collagen synthesis of human ito cells in culture , 1995, Hepatology.

[101]  D. Rockey,et al.  Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis , 1994, The Journal of cell biology.

[102]  C. S. Gal,et al.  Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway. , 1995, The Journal of clinical investigation.

[103]  F. Ridolfi,et al.  Fibrogenic effect of oxidative stress on rat hepatic stellate cells , 1998, Hepatology.

[104]  J. Saklatvala,et al.  Interleukin-1 inhibits the synthesis of collagen by fibroblasts. , 1986, Biochemistry international.

[105]  M. Ziol,et al.  A histopathological study of the effects of 6-month versus 12-month interferon alpha-2b therapy in chronic hepatitis C. , 1996, Journal of Hepatology.

[106]  M. Chojkier,et al.  A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C. , 1997, Gastroenterology.

[107]  J. Heath,et al.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.

[108]  D. Rockey,et al.  Regulation of Endothelin-1 Synthesis by Endothelin-converting Enzyme-1 during Wound Healing* , 1999, The Journal of Biological Chemistry.

[109]  D. Rifkin,et al.  Requirement for receptor‐bound urokinase in plasmin‐dependent cellular conversion of latent TGF‐β to TGF‐β , 1994 .

[110]  A. Casini,et al.  Acetaldehyde induces c-fos and c-jun proto-oncogenes in fat-storing cell cultures through protein kinase C activation. , 1994, Alcohol and alcoholism.

[111]  R. F. McGuire,et al.  Role of extracellular matrix in regulating fenestrations of sinusoidal endothelial cells isolated from normal rat liver , 1992, Hepatology.

[112]  V. Paradis,et al.  Expression of connective tissue growth factor in experimental rat and human liver fibrosis , 1999, Hepatology.

[113]  V. Rogiers,et al.  Transforming growth factor-β gene expression in normal and fibrotic rat liver , 1997 .

[114]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[115]  D. Schuppan,et al.  Kupffer cell–derived 95‐kd type IV collagenase/gelatinase B: Characterization and expression in cultured cells , 1995, Hepatology.

[116]  A. Rosman,et al.  Differential depletion of carotenoids and tocopherol in liver disease , 1993, Hepatology.

[117]  H. Nakshatri,et al.  The Platelet-activating Factor Receptor Protects Epidermal Cells from Tumor Necrosis Factor (TNF) α and TNF-related Apoptosis-inducing Ligand-induced Apoptosis through an NF-κB-dependent Process* , 2001, The Journal of Biological Chemistry.

[118]  C. Lieber,et al.  Hepatic Fibrosis After Long‐Term Administration of Ethanol and Moderate Vitamin A Supplementation in the Rat , 2007, Hepatology.

[119]  S. Friedman,et al.  Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. , 1994, The Journal of clinical investigation.

[120]  D. Rockey,et al.  Cellular localization of endothelin‐1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells , 1998, Hepatology.

[121]  J. Friedman,et al.  Obesity in the new millennium , 2000, Nature.

[122]  D. Brenner,et al.  The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. , 1999, Journal of hepatology.

[123]  P. Greenwel,et al.  Characterization of fat-storing cell lines derived from normal and CCl4-cirrhotic livers. Differences in the production of interleukin-6. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[124]  L. Videla,et al.  Content of hepatic reduced glutathione in chronic alcoholic patients: influence of the length of abstinence and liver necrosis. , 1984, Clinical science.

[125]  Wei Wu,et al.  Interleukin‐10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice , 1998, Hepatology.

[126]  G. Svegliati-Baroni,et al.  Intracellular signaling pathways involved in acetaldehyde‐induced collagen and fibronectin gene expression in human hepatic stellate cells , 2001, Hepatology.

[127]  P. Marcellin,et al.  Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method. , 1998, Journal of hepatology.

[128]  A. Gressner,et al.  The response of rat liver perisinusoidal lipocytes to polypeptide growth regulator changes with their transdifferentiation into myofibroblast-like cells in culture. , 1993, Journal of hepatology.

[129]  M. Shibuya,et al.  Inhibition of hepatic stellate cell contraction during activation in vitro by vascular endothelial growth factor in association with upregulation of FLT tyrosine kinase receptor family, FLT-1. , 1999, Biochemical and biophysical research communications.

[130]  J. Rosenbloom,et al.  Selective inhibition of human diploid fibroblast collagen synthesis by interferons. , 1984, The Journal of clinical investigation.

[131]  K. Tsuneyama,et al.  Histopathology of Primary Biliary Cirrhosis with Emphasis on Expression of Adhesion Molecules , 1997, Seminars in liver disease.

[132]  S. Friedman,et al.  Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing , 1998, Oncogene.

[133]  A. Gressner,et al.  A cascade-mechanism of fat storing cell activation forms the basis of the fibrogenic reaction of the liver. , 1995, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[134]  R W Alexander,et al.  Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. , 1994, Circulation research.

[135]  A. Benedetti,et al.  Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis , 1996, Hepatology.

[136]  A. Nanji,et al.  Intercellular Adhesion Molecule-1 Expression in Experimental Alcoholic Liver Disease: Relationship to Endotoxemia and TNFα Messenger RNA , 1995 .

[137]  D M Bissell,et al.  Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. , 1995, The Journal of clinical investigation.

[138]  S. Thorgeirsson,et al.  Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. , 1990, The Journal of clinical investigation.

[139]  K. Wake,et al.  Suppression of experimental hepatic fibrosis by administration of vitamin A. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[140]  C. Lieber,et al.  Hepatotoxicity of vitamin A and ethanol in the rat. , 1982, Gastroenterology.

[141]  S. Friedman,et al.  Inhibition of rat hepatic lipocyte activation in culture by interferon‐γ , 1992, Hepatology.

[142]  E. Mezey,et al.  Identification of new sites of binding and activation of the murine α1(I) collagen promoter by CCAAT/enhancer binding protein β , 2001 .

[143]  Transforming growth factor β signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts , 2001 .

[144]  A. Gressner,et al.  Bidirectional effects of Kupffer cells on hepatocyte proliferation in vitro , 1991, FEBS letters.

[145]  B. Bacon,et al.  Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury. , 1999, The Journal of laboratory and clinical medicine.

[146]  B. Bacon,et al.  Effect of vitamin E supplementation on hepatic fibrogenesis in chronic dietary iron overload. , 1997, The American journal of physiology.

[147]  Yun Wang,et al.  Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells , 2000, Hepatology.

[148]  T. Izumi,et al.  Role of PAF in Acute Liver Injury After Extended Hepatectomy , 2001, Digestive Diseases and Sciences.

[149]  R. Mason,et al.  Free radicals in toxicology. , 1993, Toxicology and applied pharmacology.

[150]  D. Hanahan,et al.  Biosynthesis of platelet-activating factor by cultured rat Kupffer cells stimulated with calcium ionophore A23187. , 1989, The Biochemical journal.

[151]  C. Lieber,et al.  Hepatic vitamin A depletion in alcoholic liver injury. , 1982, The New England journal of medicine.

[152]  F. Oberti,et al.  Effects of long-term administration of interferon α in two models of liver fibrosis in rats , 1998 .

[153]  S. Friedman,et al.  Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. , 1989, The Journal of clinical investigation.

[154]  S. Milani,et al.  Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. , 1996, Gastroenterology.

[155]  S. Milani,et al.  Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. , 1998, The American journal of pathology.

[156]  N. Davidson,et al.  Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production. , 1990, The Journal of clinical investigation.

[157]  D. Adams,et al.  Expression of E‐selectin and E‐selectin ligands in human liver inflammation , 1996, Hepatology.

[158]  I. Hernández-Muñoz,et al.  Tumor necrosis factor alpha inhibits collagen alpha 1(I) gene expression in rat hepatic stellate cells through a G protein. , 1997, Gastroenterology.

[159]  B. Bacon,et al.  Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells. , 1997, American journal of physiology. Gastrointestinal and liver physiology.

[160]  R. Ross,et al.  Two classes of PDGF receptor recognize different isoforms of PDGF. , 1988, Science.

[161]  D. Rockey,et al.  Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[162]  J. Iredale,et al.  Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors , 2001, Gut.

[163]  V. Carloni,et al.  Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. , 1995, Gastroenterology.

[164]  J. Ward,et al.  Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice. , 1993, Cancer research.

[165]  V. Carloni,et al.  Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. , 1997, Gastroenterology.

[166]  J. Seyer,et al.  Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin-1 beta, tumor necrosis factor alpha, and transforming growth factor beta in Ito cells. , 1992, Journal of Biological Chemistry.

[167]  K. Mak,et al.  Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. , 1984, Gastroenterology.

[168]  G. Habermehl,et al.  Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. , 1989, The Biochemical journal.

[169]  D. Rockey,et al.  Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing. , 1996, The Journal of clinical investigation.

[170]  M. Arthur,et al.  Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin‐10 during the course of activation in vitro , 1998, Hepatology.

[171]  P. Muriel,et al.  Remission of liver fibrosis by interferon-α2b , 1995 .

[172]  D. Rifkin,et al.  TGF‐β Latency: Biological Significance and Mechanisms of Activation , 1997 .

[173]  M. Sporn,et al.  Induction of transforming growth factor-α in activated human alveolar macrophages , 1988, Cell.

[174]  S. Friedman,et al.  Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. , 1989, The Journal of clinical investigation.

[175]  A. Pietrangelo Iron, oxidative stress and liver fibrogenesis. , 1998, Journal of hepatology.

[176]  R. Chamuleau,et al.  Collagen synthesis by human liver (myo)fibroblasts in culture: evidence fora regulatory role of IL-1β,IL-4, TGFβ and IFN gamma , 1995 .

[177]  S. Strömblad,et al.  Increased expression of and sensitivity to transforming growth factor‐α: A promotive role during rat liver carcinogenesis , 1994, Molecular carcinogenesis.

[178]  D. Bissell Hepatic fibrosis as wound repair: A progress report , 1998, Journal of Gastroenterology.

[179]  B. Neuschwander‐Tetri,et al.  Manipulation of glutathione stores in rat hepatic stellate cells does not alter collagen synthesis , 1997, Hepatology.

[180]  M. Lerner,et al.  Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. , 1993, The Journal of biological chemistry.

[181]  D. Adams,et al.  Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease , 1994, Hepatology.

[182]  A. Burt,et al.  In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. , 1993, The American journal of pathology.

[183]  H. Hendriks,et al.  Fat-Storing Cells: Hyper- and Hypovitaminosis A and the Relationships with Liver Fibrosis , 1993, Seminars in liver disease.

[184]  R. Burk,et al.  Relationship of oxygen and glutathione in protection against carbon tetrachloride-induced hepatic microsomal lipid peroxidation and covalent binding in the rat. Rationale for the use of hyperbaric oxygen to treat carbon tetrachloride ingestion. , 1984, The Journal of clinical investigation.

[185]  E. Mezey,et al.  CCAAT/Enhancer Binding Protein β Mediates the Activation of the Murine α1(I) Collagen Promoter by Acetaldehyde , 2000 .

[186]  M. Arthur,et al.  Rat hepatic lipocytes synthesize and secrete transin (stromelysin) in early primary culture. , 1995, Gastroenterology.

[187]  G. Ramadori,et al.  Characterization of the IGF axis components in isolated rat hepatic stellate cells , 1998, Hepatology.

[188]  V. Ferrans,et al.  Requirement for Generation of H2O2 for Platelet-Derived Growth Factor Signal Transduction , 1995, Science.

[189]  B. Bacon,et al.  Hepatic lipid peroxidation in vivo in rats with chronic iron overload. , 1983, The Journal of clinical investigation.

[190]  A. Gressner,et al.  Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. , 1992, The Journal of clinical investigation.

[191]  I. Sternlieb,et al.  Copper and the liver. , 1980, Gastroenterology.

[192]  S. Friedman,et al.  DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. , 2001, The Journal of clinical investigation.

[193]  A. Pietrangelo,et al.  Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. , 1995, The Journal of clinical investigation.

[194]  B. Portmann,et al.  Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. , 1995, Gastroenterology.

[195]  A. Rivas-Estilla,et al.  Hydrogen peroxide: A link between acetaldehyde‐elicited α1(i) collagen gene up‐regulation and oxidative stress in mouse hepatic stellate cells , 2000, Hepatology.

[196]  J. Morrow,et al.  Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver. , 2001, Journal of lipid research.

[197]  I. Issemann,et al.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators , 1990, Nature.

[198]  A. Gressner,et al.  Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type β1 and type α , 1990 .

[199]  M. Sporn,et al.  Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[200]  A. Cederbaum,et al.  Induction of catalase, alpha, and microsomal glutathione S‐transferase in CYP2E1 overexpressing HepG2 cells and protection against short‐term oxidative stress , 2001, Hepatology.

[201]  G. Vendemiale,et al.  Hepatic glutathione content in patients with alcoholic and non alcoholic liver diseases. , 1988, Life sciences.

[202]  J. Prieto,et al.  Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis C , 1996, Hepatology.

[203]  E. González‐Reimers,et al.  Cytokine levels in acute alcoholic hepatitis: a sequential study. , 1995, Drug and alcohol dependence.

[204]  G. Gores,et al.  Liver cell necrosis: cellular mechanisms and clinical implications. , 1995, Gastroenterology.

[205]  D. Fuchs,et al.  Neopterin and soluble tumor necrosis factor receptor type I in alcohol‐induced cirrhosis , 1995, Hepatology.

[206]  D. Schuppan,et al.  Acetaldehyde regulates the gene expression of matrix-metalloproteinase-1 and -2 in human fat-storing cells. , 1994, Life sciences.

[207]  R. Evans,et al.  Corepressors and nuclear hormone receptor function. , 2001, Current topics in microbiology and immunology.

[208]  Y. Hasumura,et al.  The Role of Fat‐Storing Cells in Disse Space Fibrogenesis in Alcoholic Liver Disease , 2007, Hepatology.

[209]  M. Shibuya,et al.  Expressions of vascular endothelial growth factor in nonparenchymal as well as parenchymal cells in rat liver after necrosis. , 1999, Biochemical and biophysical research communications.

[210]  S. Seki,et al.  Effect of antioxidants, resveratrol, quercetin, and N‐acetylcysteine, on the functions of cultured rat hepatic stellate cells and kupffer cells , 1998, Hepatology.

[211]  P. Muriel Alpha-interferon prevents liver collagen deposition and damage induced by prolonged bile duct obstruction in the rat. , 1996, Journal of hepatology.